Suppr超能文献

胆囊癌的综合分子特征分析揭示了与微环境相关的亚型。

Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes.

机构信息

Biotech Research and Innovation Centre, Department of Health and Medical Sciences, University of Copenhagen, Denmark.

Division of Cancer Epidemiology and Genetics, NIH, Rockville, MD, USA.

出版信息

J Hepatol. 2021 May;74(5):1132-1144. doi: 10.1016/j.jhep.2020.11.033. Epub 2020 Dec 1.

Abstract

BACKGROUND & AIMS: Gallbladder cancer (GBC) is the most common type of biliary tract cancer, but the molecular mechanisms involved in gallbladder carcinogenesis remain poorly understood. In this study, we applied integrative genomics approaches to characterise GBC and explore molecular subtypes associated with patient survival.

METHODS

We profiled the mutational landscape of GBC tumours (whole-exome sequencing on 92, targeted sequencing on 98, in total 190 patients). In a subset (n = 45), we interrogated the matched transcriptomes, DNA methylomes, and somatic copy number alterations. We explored molecular subtypes identified through clustering tumours by genes whose expression was associated with survival in 47 tumours and validated subtypes on 34 publicly available GBC cases.

RESULTS

Exome analysis revealed TP53 was the most mutated gene. The overall mutation rate was low (median 0.82 Mut/Mb). APOBEC-mediated mutational signatures were more common in tumours with higher mutational burden. Aflatoxin-related signatures tended to be highly clonal (present in ≥50% of cancer cells). Transcriptome-wide survival association analysis revealed a 95-gene signature that stratified all GBC patients into 3 subtypes that suggested an association with overall survival post-resection. The 2 poor-survival subtypes were associated with adverse clinicopathologic features (advanced stage, pN1, pM1), immunosuppressive micro-environments (myeloid-derived suppressor cell accumulation, extensive desmoplasia, hypoxia) and T cell dysfunction, whereas the good-survival subtype showed the opposite features.

CONCLUSION

These data suggest that the tumour micro-environment and immune profiles could play an important role in gallbladder carcinogenesis and should be evaluated in future clinical studies, along with mutational profiles.

LAY SUMMARY

Gallbladder cancer is highly fatal, and its causes are poorly understood. We evaluated gallbladder tumours to see if there were differences between tumours in genetic information such as DNA and RNA. We found evidence of aflatoxin exposure in these tumours, and immune cells surrounding the tumours were associated with survival.

摘要

背景与目的

胆囊癌(GBC)是最常见的胆道癌类型,但胆囊癌发生的分子机制仍知之甚少。在本研究中,我们应用整合基因组学方法来描述 GBC 并探索与患者生存相关的分子亚型。

方法

我们对 GBC 肿瘤的突变景观进行了分析(92 例进行全外显子组测序,98 例进行靶向测序,共 190 例患者)。在一个亚组(n=45)中,我们检测了匹配的转录组、DNA 甲基组和体细胞拷贝数改变。我们通过聚类分析 47 例肿瘤中与生存相关的基因表达来探索分子亚型,并在 34 例公开的 GBC 病例中验证了这些亚型。

结果

外显子组分析显示 TP53 是突变最多的基因。总的突变率较低(中位数 0.82 Mut/Mb)。APOBEC 介导的突变特征在突变负荷较高的肿瘤中更为常见。黄曲霉毒素相关特征往往是高度克隆的(存在于≥50%的癌细胞中)。全转录组生存关联分析显示,95 个基因的特征可将所有 GBC 患者分为 3 种亚型,提示与术后总生存有关。2 种不良生存亚型与不良临床病理特征(晚期、pN1、pM1)、免疫抑制微环境(髓系来源抑制细胞积累、广泛纤维变性、缺氧)和 T 细胞功能障碍相关,而良好生存亚型则表现出相反的特征。

结论

这些数据表明,肿瘤微环境和免疫谱可能在胆囊癌的发生中发挥重要作用,应该与突变谱一起在未来的临床研究中进行评估。

平铺直叙

胆囊癌的死亡率很高,其病因尚不清楚。我们评估了胆囊肿瘤,以观察肿瘤的 DNA 和 RNA 等遗传信息是否存在差异。我们在这些肿瘤中发现了黄曲霉毒素暴露的证据,并且肿瘤周围的免疫细胞与生存相关。

相似文献

1
Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes.
J Hepatol. 2021 May;74(5):1132-1144. doi: 10.1016/j.jhep.2020.11.033. Epub 2020 Dec 1.
2
Mutational spectrum and precision oncology for biliary tract carcinoma.
Theranostics. 2021 Mar 4;11(10):4585-4598. doi: 10.7150/thno.56539. eCollection 2021.
3
Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder.
Signal Transduct Target Ther. 2021 Feb 10;6(1):55. doi: 10.1038/s41392-020-00412-3.
4
Comprehensive mutational profiling identifies new driver events in cutaneous leiomyosarcoma.
Br J Dermatol. 2025 Jan 24;192(2):335-343. doi: 10.1093/bjd/ljae386.
5
Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer.
PLoS One. 2018 Nov 5;13(11):e0206643. doi: 10.1371/journal.pone.0206643. eCollection 2018.
8
Mutational landscape of paired primary and synchronous metastatic lymph node in chemotherapy naive gallbladder cancer.
Mol Biol Rep. 2022 Feb;49(2):1295-1301. doi: 10.1007/s11033-021-06957-y. Epub 2022 Jan 5.
9
Association of Aflatoxin and Gallbladder Cancer.
Gastroenterology. 2017 Aug;153(2):488-494.e1. doi: 10.1053/j.gastro.2017.04.005. Epub 2017 Apr 17.

引用本文的文献

1
Immunotherapy in biliary tract cancer: reshaping the tumour microenvironment and advancing precision combination strategies.
Front Immunol. 2025 Aug 8;16:1651769. doi: 10.3389/fimmu.2025.1651769. eCollection 2025.
3
Characterization of Mutational Signatures in Tumors from a Large Chinese Population.
Cancer Res Commun. 2025 Aug 1;5(8):1466-1476. doi: 10.1158/2767-9764.CRC-24-0496.
6
Spatial and temporal dynamics in progressive gallbladder cancer.
Nat Genet. 2025 Jun 26. doi: 10.1038/s41588-025-02232-z.
7
Development and challenges in the treatment of advanced gallbladder cancer (Review).
Oncol Lett. 2025 Jun 3;30(2):382. doi: 10.3892/ol.2025.15128. eCollection 2025 Aug.
8
Advances in diagnosis and treatment of gallbladder cancer: Current status and future directions.
World J Gastrointest Oncol. 2025 May 15;17(5):104957. doi: 10.4251/wjgo.v17.i5.104957.
9
Liquid biopsy in gallbladder carcinoma: Current evidence and future prospective.
J Liq Biopsy. 2024 Nov 26;6:100280. doi: 10.1016/j.jlb.2024.100280. eCollection 2024 Dec.

本文引用的文献

3
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma.
Nat Med. 2019 Mar;25(3):462-469. doi: 10.1038/s41591-019-0349-y. Epub 2019 Feb 11.
4
Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.
Cancer. 2019 May 1;125(9):1489-1498. doi: 10.1002/cncr.31942. Epub 2019 Jan 15.
6
FusionGDB: fusion gene annotation DataBase.
Nucleic Acids Res. 2019 Jan 8;47(D1):D994-D1004. doi: 10.1093/nar/gky1067.
7
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.
Nat Med. 2018 Oct;24(10):1550-1558. doi: 10.1038/s41591-018-0136-1. Epub 2018 Aug 20.
8
Genomic / mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis.
Gut. 2019 Jun;68(6):1024-1033. doi: 10.1136/gutjnl-2018-316039. Epub 2018 Jun 28.
9
Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer.
Sci Rep. 2018 Apr 4;8(1):5671. doi: 10.1038/s41598-018-23848-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验